Literature DB >> 13711083

Factors affecting the absorption and biliary excretion of erythromycin and two of its derivatives in humans.

J B HAMMOND, R S GRIFFITH.   

Abstract

Entities:  

Keywords:  BILE/chemistry; ERYTHROMYCIN/metabolism

Mesh:

Substances:

Year:  1961        PMID: 13711083     DOI: 10.1002/cpt196123308

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Excretion of oleandomycin in human bile.

Authors:  F W PRESTON; M SILVERMAN; G C HENEGAR; J C KUKRAL
Journal:  Am J Dig Dis       Date:  1962-06

3.  Erythromycin in renal failure.

Authors:  M S Wheeley
Journal:  Br Med J       Date:  1977-08-20

4.  Biliary excretion of erythromycin after parenteral administration.

Authors:  P Chelvan; J M Hamilton-Miller; W Brumfitt
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

5.  Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects.

Authors:  P D Kroboth; A Brown; J A Lyon; F J Kroboth; R P Juhl
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Intersubject and dose-related variability after intravenous administration of erythromycin.

Authors:  K L Austin; L E Mather; C R Philpot; P J McDonald
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

7.  Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.

Authors:  D Croteau; M G Bergeron; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.